87 related articles for article (PubMed ID: 2812153)
1. HLA antigens and bronchogenic carcinoma.
Prazák J; Mĕricka O
Neoplasma; 1989; 36(5):599-602. PubMed ID: 2812153
[TBL] [Abstract][Full Text] [Related]
2. [HLA-A, B antigens and bronchogenic pulmonary carcinoma].
Prazák J; Mĕricka O
Cas Lek Cesk; 1987 Aug; 126(34):1081-2. PubMed ID: 3478139
[No Abstract] [Full Text] [Related]
3. Histocompatibility locus antigens (HLA) in the epidermoid type of lung carcinoma.
Prazák J; Mĕricka O; Chytrý J
J Cancer Res Clin Oncol; 1990; 116(5):525-7. PubMed ID: 2229145
[TBL] [Abstract][Full Text] [Related]
4. HLA antigens and bronchogenic carcinoma in the Greek population.
Toumbis M; Zervas J; Anagnostopoulou O; Konstantopoulos K; Krimbeni G; Kotsovoulou V; Fessas F
Acta Oncol; 1991; 30(5):575-8. PubMed ID: 1654063
[TBL] [Abstract][Full Text] [Related]
5. HLA and survival in lung cancer.
Mottironi VD; Banks SM; Pollara B; Rudofsky UH
Clin Immunol Immunopathol; 1987 Oct; 45(1):55-62. PubMed ID: 3476226
[TBL] [Abstract][Full Text] [Related]
6. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic status of patients with bronchogenic carcinoma of the lung].
Rowińska-Zakrzewska E; Byszewska D; Grubek-Jaworska H; Zabuska-Jabłońska K; Plucińska M
Pneumonol Pol; 1979 Apr; 47(4):221-30. PubMed ID: 313046
[No Abstract] [Full Text] [Related]
8. Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5. A two-year prospective study.
Rogentine CN; Dellon AL; Chretien PB
Cancer; 1977 Jun; 39(6):2345-7. PubMed ID: 872033
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
10. HLA antigens in bronchogenic carcinoma.
Sengar DP; McLeish WA; Stewart TH; Harris JE
Oncology; 1977; 34(4):143-5. PubMed ID: 917446
[TBL] [Abstract][Full Text] [Related]
11. HLA system and some neoplastic diseases.
Abrahámová J; Májský A
Acta Univ Carol Med Monogr; 1988; 123():1-80. PubMed ID: 3071120
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen in bronchogenic carcinoma.
Zatloukal P; Voslárová Z; Mĕricka O; Svarcová H; Schützner J
Neoplasma; 1987; 34(1):73-6. PubMed ID: 3561607
[TBL] [Abstract][Full Text] [Related]
13. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
14. HLA and adult T cell leukaemia: HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I.
Uno H; Kawano K; Matsuoka H; Tsuda K
Clin Exp Immunol; 1988 Feb; 71(2):211-6. PubMed ID: 2894907
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
[TBL] [Abstract][Full Text] [Related]
16. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
[TBL] [Abstract][Full Text] [Related]
17. [Distribution of histocompatibility antigens in patients with pulmonary tuberculosis depending on disease course and immune response pattern].
Knoring BE; Berkos AS; Sakharova IIa
Probl Tuberk; 1995; (2):16-9. PubMed ID: 7777453
[TBL] [Abstract][Full Text] [Related]
18. HLA as an immunogenetic risk factor in juvenile chronic arthritis.
Matej H; Kałamarz M; Nowakowska B; Prusek W; Podwysocka M; Wieczorek E; Zahorska Z
Arch Immunol Ther Exp (Warsz); 1987; 35(6):787-94. PubMed ID: 3508038
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between nasopharyngeal carcinoma and HLA in Sichuan].
Yuan BW
Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):263-6. PubMed ID: 3248481
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating T alpha lymphocyte population in bronchogenic and colonic carcinoma.
Pucci A; Clancy RL; Doe WF
Clin Exp Immunol; 1981 Oct; 46(1):130-3. PubMed ID: 6978211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
